Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents;Prevalencia de candidiasis vaginal en embarazadas. Identificación de levaduras y sensibilidad a los antifúngicos

Revista Argentina de Microbiologia

Volumn 38, Issue 1, 2006, Pages 9-12

  Garcia Heredia M ^a   Garcia S D ^b   Copolillo, E F ^b   Eliseth, M Cora ^b   Barata, A D ^b   Vay, C A ^b   De Torres, R A ^a   Tiraboschi, N ^b   Famiglietti, A M R ^b  

^a Facultad de Farmacia y Bioquimica   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Antifungal resistance; Candidiasis; Pregnancy

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; NISTATINE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KEFYR; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ARGENTINA; CANDIDA; CANDIDIASIS, VULVOVAGINAL; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SPECIES SPECIFICITY;

EID: 33745134385     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Balaka B, Agbere AD, Baeta S, Kessie K, Assimadi K. Bacterial flora in the genital tract the last trimester of pregnancy. J Gynecol Obstet Biol Reprod 2003; 32: 555-61.
2. Bauters TGM, Dhont MA, Temmerman MIL, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol 2002; 187: 569-74.
3. Buscemi L, Arechavala A, Negroni R. Estudio de las vulvovaginitis agudas en pacientes adultas, sexualmente activas, con especial referencia a la candidiasis, en pacientes del hospital de infecciosas Francisco J. Muñiz. Rev Iberoam Micol 2004; 21: 177-81.
4. Carrillo-Muńoz AJ, Abarca L, Quindós G, Arévalo P, Bornay F, Cabañes FJ, et al. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing. Rev Iberoam Micol 1999; 16: 92-6.
5. Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 2003; 110: 66-72.
6. Erdem H, Cetin M, Timuroglu T, Cetin A, Yanar O, Pahsa A. Identification of yeast in public hospital primary care patients with or without clinical vaginitis. J Gynecol 2003; 43: 312-6.
7. Eschenbach DA. Chronic vulvovaginal candidiasis. N Engl J Med 2004; 351: 851-2.
8. Fidel PL, Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, et al. An intravaginal live Candida challenge in humans leads to new hypothesis for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 2004; 72: 2939-46.
9. Fidel PL, Vázquez JA, Sobel JD. Candida glabrata: review of epidemiology pathogenesis and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12: 80-96.
10. García-Martos P, Domínguez I, Marín P, García-Agudo R, Avofi S, Mira J. Sensibilidad a antifúngicos de levaduras patógenas emergentes. Enferm Infecc Microbiol Clin 2001; 19: 249-56.
11. Holland J, Young ML, Lee O, Chen SC-A. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 2003; 79: 249-50.
12. Namkinga LA, Matee MI, Kivaisi AK, Kullaya A, Mneney EE. Identification of Candida strains isolated from Tanzanian pregnant women with vaginal candidiasis. East Afr Med J 2005; 82: 226-34.
13. Mac Neill C, Weisz J, Carey JC. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. J Reprod Med 2003; 48: 63-8.
14. Margariti PA, Astorri AL, Mastromarino C, Morace G. Mycotic vulvovaginitis. Recenti Prog Med 1997; 88: 479-84.
15. Mujica MT, Finquelievich JL, Jewtuchowicz CA, Iovannitti CA. Prevalencia de Candida albicans y Candida no albicans en diferentes muestras clínicas. Período 1999-2001. Rev Arg Microbiol 2004; 36: 107-12.
16. Negroni R, Guelfand L. Manual de procedimientos para laboratorios de Micología Médica. Acta Bioquím Clín Latinoam 1999; Supl. 1.
17. Omar AA. Gram stain versus culture in the diagnosis of vulvovaginal candidiasis. East Mediterr Health J 2001; 7: 925-34.
18. Reyna Figueroa J, Morales Range V, Ortiz Ibarra FJ, Casanova Román G, Beltrán Zúniga M. Effectiveness of a clinimetric scale for diagnosing vulvovaginal candidosis. Ginecol Obstet Mex 2004; 72: 219-26.
19. Rylander E, Berglund A-L, Krassny C, Petrini B. Vulvo-vaginal Candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect 2004; 80: 54-7.
20. Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L. Candidiasis vaginal: etiología y perfil de sensibilidad a agentes antifúngicos de uso clínico. Rev Arg Microbiol 2001; 33: 217-22.
21. Sobel JD, Harold C, Wiesenfeld HC, Martens M, Danna P, Hooton TM, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004; 351: 876-83.
22. Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother 2003; 47: 34-8.
23. Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 2004; 15: 163-9.